You are here

  • Home
  • Archive
  • Volume 3, Issue 6
  • MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study

Article metrics

Article menu

Download PDFPDF

XML
Neurology
Research
MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study

 

Online download statistics by month:

Online download statistics by month: January 2018 to April 2024

AbstractFullPdf
Jan 201811911319
Feb 20181591344
Mar 2018514410
Apr 20181038715
May 20181491459
Jun 2018483510
Jul 2018432716
Aug 2018514516
Sep 2018969015
Oct 201883799
Nov 20181059210
Dec 2018645013
Jan 201947409
Feb 201936339
Mar 2019453413
Apr 2019372914
May 2019191111
Jun 2019221210
Jul 201916151
Aug 2019181511
Oct 2019362412
Nov 201936345
Dec 201928203
Jan 2020231711
Feb 202022128
Mar 2020774
May 202014611
Jun 202024163
Jul 202023146
Aug 202017132
Sep 202023145
Oct 202044327
Nov 2020482810
Dec 202026197
Jan 202128218
Feb 202128109
Mar 2021161213
Apr 202130278
May 2021332815
Jun 202113137
Jul 202120207
Aug 2021161612
Sep 202125249
Oct 2021352825
Nov 2021211117
Dec 202125173
Jan 202234265
Feb 202225209
Mar 202242248
Apr 202239229
May 2022271917
Jun 2022311514
Jul 202230163
Aug 2022352310
Sep 2022141128
Oct 202219136
Nov 202234198
Dec 202230194
Jan 202350376
Feb 2023271610
Mar 202353489
Apr 20232588
May 2023342013
Jun 2023483417
Jul 2023271311
Aug 20232198
Sep 202354505
Oct 202388775
Nov 202356182
Dec 2023846413
Jan 202445458
Feb 2024916510
Mar 2024423350
Apr 20241398
Total30902386755